INS and diabetes mellitus: Recent study reports significantly that exendin-4, a new drug for DM, activates the common pathway of insulin signal transduction by stimulating glucagon-like peptide-1 (GLP-1) receptor, thus blocking the damage of insulin signal transduction in hippocampal neurons, reversing insulin pathology and improving the cognitive ability of mice37.